Search research articles
Contact Us
Filters
Showing results (61-70 of 560) with videos related to
Page
of 56
Sort By:
Hematology/Oncology Clinics of North America
|
August 11, 1992
Oncogenes in ovarian cancer
A Berchuck, M F Kohler, R C Bast
Journal of the National Cancer Institute
|
October 5, 2001
Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics
G B Mills, R C Bast, S Srivastava
Hematology/Oncology Clinics of North America
|
November 5, 2018
Early Detection of Ovarian Cancer
Kevin M Elias, Jing Guo, Robert C Bast
Clinical Obstetrics and Gynecology
|
March 11, 1992
The use of tumor markers in the management of patients with gynecologic carcinomas
A Berchuck, M P Boente, R C Bast
Cancer
|
October 15, 1987
Pros and cons of gynecologic tumor markers
R C Bast, V Hunter, R C Knapp
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1971
Morphologic changes in draining lymph nodes and in lymphocyte cultures after sensitization with complete or incomplete Freund's adjuvant. Correlation with immunologic events in vivo and in culture
A M Dvorak, R C Bast, H F Dvorak
BJOG : an International Journal of Obstetrics and Gynaecology
|
December 16, 2011
The origin of ovarian cancer
A A Ahmed, C M Becker, R C Bast
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 5, 2002
Translational research--traffic on the bridge
R C Bast, G B Mills, R C Young
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|
January 1, 1989
Pharmacokinetics of a radioiodinated monoclonal antibody F(ab')2 fragment in a xenograft model with circulating antigen
M R Zalutsky, R C Bast, R C Knapp
Obstetrics and Gynecology
|
September 11, 1992
Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3
I J Jacobs, D H Oram, R C Bast
Page
of 56
Search research articles
Search
Showing results (61-70 of 560) with videos related to
Sort By:
Page
of 56
Hematology/Oncology Clinics of North America
|
August 11, 1992
Oncogenes in ovarian cancer
A Berchuck, M F Kohler, R C Bast
Journal of the National Cancer Institute
|
October 5, 2001
Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics
G B Mills, R C Bast, S Srivastava
Hematology/Oncology Clinics of North America
|
November 5, 2018
Early Detection of Ovarian Cancer
Kevin M Elias, Jing Guo, Robert C Bast
Clinical Obstetrics and Gynecology
|
March 11, 1992
The use of tumor markers in the management of patients with gynecologic carcinomas
A Berchuck, M P Boente, R C Bast
Cancer
|
October 15, 1987
Pros and cons of gynecologic tumor markers
R C Bast, V Hunter, R C Knapp
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1971
Morphologic changes in draining lymph nodes and in lymphocyte cultures after sensitization with complete or incomplete Freund's adjuvant. Correlation with immunologic events in vivo and in culture
A M Dvorak, R C Bast, H F Dvorak
BJOG : an International Journal of Obstetrics and Gynaecology
|
December 16, 2011
The origin of ovarian cancer
A A Ahmed, C M Becker, R C Bast
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 5, 2002
Translational research--traffic on the bridge
R C Bast, G B Mills, R C Young
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|
January 1, 1989
Pharmacokinetics of a radioiodinated monoclonal antibody F(ab')2 fragment in a xenograft model with circulating antigen
M R Zalutsky, R C Bast, R C Knapp
Obstetrics and Gynecology
|
September 11, 1992
Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3
I J Jacobs, D H Oram, R C Bast
Page
of 56